Zobrazeno 1 - 10
of 17
pro vyhledávání: ''
Autor:
Emil Hagström, Karin Littmann, Jonas Brinck, Paolo Parini, Mats Eriksson, Henrike Häbel, Matteo Bottai
Publikováno v:
European Journal of Preventive Cardiology. 28:2038-2047
Aims To investigate plasma lipoprotein(a) [Lp(a)] levels measured in routine clinical care and their association with mortality and cardiovascular disease. Methods and results This retrospective registry-based observational cohort study includes all
Autor:
Joline W. J. Beulens, Kenneth J. Mukamal, Lars O. Dragsted, Donna Spiegelman, Diederick E. Grobbee, Howard J. Edenberg, Margaret M. Murray, Janelle W. Coughlin, Sally N. Adebamowo, Lawrence J. Appel, Eric B. Rimm, Jane N. Eriksen, Jeff D. Williamson, Ilse C. Schrieks, Polyna Khudyakov, Vilma Irazola, Ramon Estruch, Pablo Gulayin, Clement Adebamowo, John H. Krystal, T.L. Wilkens, Laura C. Lovato, Mariana Lazo
Publikováno v:
Eur J Prev Cardiol
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
European Journal of Preventive Cardiology, 27(18), 1967-1982. SAGE Publications Ltd
Spiegelman, D, Lovato, L C, Khudyakov, P, Wilkens, T L, Adebamowo, C A, Adebamowo, S N, Appel, L J, Beulens, J W J, Coughlin, J W, Dragsted, L O, Edenberg, H J, Eriksen, J N, Estruch, R, Grobbee, D E, Gulayin, P E, Irazola, V, Krystal, J H, Lazo, M, Murray, M M, Rimm, E B, Schrieks, I C, Williamson, J D & Mukamal, K J 2020, ' The Moderate Alcohol and Cardiovascular Health Trial (MACH15) : Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk ', European Journal of Preventive Cardiology, vol. 27, no. 18, pp. 1967-1982 . https://doi.org/10.1177/2047487320912376
Spiegelman, D, Lovato, L C, Khudyakov, P, Wilkens, T L, Adebamowo, C A, Adebamowo, S N, Appel, L J, Beulens, J W, Coughlin, J W, Dragsted, L O, Edenberg, H J, Eriksen, J N, Estruch, R, Grobbee, D E, Gulayin, P E, Irazola, V, Krystal, J H, Lazo, M, Murray, M M, Rimm, E B, Schrieks, I C, Williamson, J D & Mukamal, K J 2020, ' The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk ', European Journal of Preventive Cardiology, vol. 27, no. 18, pp. 1967-1982 . https://doi.org/10.1177/2047487320912376
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
European Journal of Preventive Cardiology, 27(18), 1967-1982. SAGE Publications Ltd
Spiegelman, D, Lovato, L C, Khudyakov, P, Wilkens, T L, Adebamowo, C A, Adebamowo, S N, Appel, L J, Beulens, J W J, Coughlin, J W, Dragsted, L O, Edenberg, H J, Eriksen, J N, Estruch, R, Grobbee, D E, Gulayin, P E, Irazola, V, Krystal, J H, Lazo, M, Murray, M M, Rimm, E B, Schrieks, I C, Williamson, J D & Mukamal, K J 2020, ' The Moderate Alcohol and Cardiovascular Health Trial (MACH15) : Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk ', European Journal of Preventive Cardiology, vol. 27, no. 18, pp. 1967-1982 . https://doi.org/10.1177/2047487320912376
Spiegelman, D, Lovato, L C, Khudyakov, P, Wilkens, T L, Adebamowo, C A, Adebamowo, S N, Appel, L J, Beulens, J W, Coughlin, J W, Dragsted, L O, Edenberg, H J, Eriksen, J N, Estruch, R, Grobbee, D E, Gulayin, P E, Irazola, V, Krystal, J H, Lazo, M, Murray, M M, Rimm, E B, Schrieks, I C, Williamson, J D & Mukamal, K J 2020, ' The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk ', European Journal of Preventive Cardiology, vol. 27, no. 18, pp. 1967-1982 . https://doi.org/10.1177/2047487320912376
Background: Observational studies have documented lower risks of coronary heart disease and diabetes among moderate alcohol consumers relative to abstainers, but only a randomized clinical trial can provide conclusive evidence for or against these as
Autor:
David R. Wood, Lale Tokgozoglu, Delphine De Smedt, Els Clays, Kornelia Kotseva, Dirk De Bacquer, Željko Reiner, Guy De Backer, Lars Rydén
Publikováno v:
European Journal of Preventive Cardiology. 27:1630-1636
Aims Recent European guidelines recommend in patients with atherosclerotic cardiovascular disease to achieve a reduction of low-density lipoprotein-cholesterol of at least 50% if the baseline low-density lipoprotein-cholesterol level is between 1.8 a
Autor:
Georgios Hatzigeorgiou, Evangelos Liberopoulos, Irene Mastorakou, Fedra Matsouka, Genovefa Kolovou, Theodoros Katsikas, Alexandros Tsoutsinos, Evangelos A. Zacharis, Epameinondas Fountas, Olga Diakoumakou, Stavros Stratakis, Sophie Mavrogeni, Vana Kolovou
Publikováno v:
European Journal of Preventive Cardiology. 27:157-165
AimsThe aim of this study was to evaluate the effect of microsomal triglyceride transfer protein inhibitor (lomitapide) in patients with homozygous familial hypercholesterolaemia.Methods and resultsIn 12 homozygous familial hypercholesterolaemia pati
Autor:
Hammad Rahman, Safi U. Khan, A. Michael Lincoff, Edo Kaluski, Steven E. Nissen, Haris Riaz, Nishant P. Shah
Publikováno v:
European Journal of Preventive Cardiology. 26:533-543
Background The effects of increasing high-density lipoprotein cholesterol on cardiovascular outcomes remain uncertain. Design We conducted a meta-analysis to investigate the effects of high-density lipoprotein cholesterol modifiers (niacin, fibrates
Autor:
Melanie Broja, J. Liebmann, Matthias Born, Michael Gröne, Manuel Stern, Simon S. Skene, Malte Kelm, Christian Heiss, Roberto Sansone, Christoph V. Suschek
Publikováno v:
European Journal of Preventive Cardiology. 25:1875-1883
Aims Previous studies have shown that ultraviolet light can lead to the release of nitric oxide from the skin and decrease blood pressure. In contrast to visible light the local application of ultraviolet light bears a cancerogenic risk. Here, we inv
Autor:
Simon L. Bacon, Andrew R Tang, Gregory A. Kline, Doreen M. Rabi, Louise Pilote, Kim L. Lavoie
Publikováno v:
European Journal of Preventive Cardiology. 25:65-72
Background Glucocorticoid excess has been linked with cardiovascular disease. Little is known about the long-term cortisol response in patients after acute coronary syndrome. Design The objective of this study was to describe the distribution of sali
Publikováno v:
European Journal of Preventive Cardiology. 24:552-558
Aims To describe the association between cardiovascular risk factors and abnormal arterial stiffness, defined by a carotid-femoral pulse wave velocity ≥ 10 m/s, in patients with chronic spinal cord injury (SCI). Methods Ninety consenting adults wit
Autor:
Ecosse L. Lamoureux, Charumathi Sabanayagam, E. Shyong Tai, Boon Wee Teo, Sunil Sethi, Wei Yan Ng, Wong Tien Yin
Publikováno v:
European Journal of Preventive Cardiology. 23:1413-1420
Serum cystatin C, a novel marker of renal function has been shown to be superior to serum creatinine in predicting renal function decline and adverse outcomes of chronic kidney disease (CKD). Our aim was to investigate the association between cystati
Publikováno v:
European Journal of Preventive Cardiology. 23:628-635
Measurement of total cholesterol is part of cardiovascular disease risk assessment in primary prevention. Frequently, old total cholesterol values are available. We assessed whether previously measured total cholesterol values could be used to estima